Optimizing Retention, Duration and Discontinuation Strategies for Addiction Pharmacotherapy (RDD)
This study is active but not recruiting. It focuses on addiction and currently lists study information in the United States.
Addiction, Addiction (OUD)BehavioralOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 21 sites
University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST)
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Tarzana Treatment Centers, Inc.
Tarzana, California
Site status: Not listed — confirm with the team
Liberation Programs, Inc.
Bridgeport, Connecticut
Site status: Not listed — confirm with the team
Operation PAR
Clearwater, Florida
Site status: Not listed — confirm with the team
Gateway Community Services
Jacksonville, Florida
Site status: Not listed — confirm with the team
Aspire Health Partners
Orlando, Florida
Site status: Not listed — confirm with the team
Mountain Manor / Maryland Treatment Centers
Baltimore, Maryland
Site status: Not listed — confirm with the team
McLean Hospital
Belmont, Massachusetts
Site status: Not listed — confirm with the team
Stanley Street Treatment and Resources, Inc.
Fall River, Massachusetts
Site status: Not listed — confirm with the team
Square Medical Group, LLC
Newton, Massachusetts
Site status: Not listed — confirm with the team
Gibson Center for Behavioral Change
Cape Girardeau, Missouri
Site status: Not listed — confirm with the team
Dartmouth Hitchcock - ATP
Lebanon, New Hampshire
Site status: Not listed — confirm with the team
University of New Mexico Addiction and Substance Abuse Program
Albuquerque, New Mexico
Site status: Not listed — confirm with the team
Bellevue Hospital Center
New York, New York
Site status: Not listed — confirm with the team
Adapt Integrated Health Care
Roseburg, Oregon
Site status: Not listed — confirm with the team
Adapt Integrated Health Care
Winston, Oregon
Site status: Not listed — confirm with the team
Center for Psychiatric and Chemical Dependency Services (CPCDS)
Pittsburgh, Pennsylvania
Site status: Not listed — confirm with the team
Internal Medicine Recovery Engagement Program (IM-REP)
Pittsburgh, Pennsylvania
Site status: Not listed — confirm with the team
Shoreline Behavioral Health Services
Conway, South Carolina
Site status: Not listed — confirm with the team
Huntsman Mental Health Institute / University of Utah
Salt Lake City, Utah
Site status: Not listed — confirm with the team
Chestnut Ridge Center
Morgantown, West Virginia
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring psychotherapy or therapy for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving SL-BUP, XR-BUP, XR-NTX, MM, MMR, MMD. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Are there criteria about substance use or wanting to reduce it?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Will I need to change, stop, or stabilize my current treatment?
The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by NYU Langone Health, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.